Systemic Chemotherapy Versus Transcatheter Arterial Chemoembolization(TACE) for Hepatocellular Carcinoma

NCT02585479 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped It doesn't meet the requirements of randomized trials

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: Pirarubicin
DRUG: Oxaliplatin
DRUG: Lipiodol
DEVICE: Gelfoam

Sponsor

Guangxi Medical University